Researchers at Johns Hopkins have taken the first step towards trials of vaginal microbiota transplantation (VMT). Inspired by the success of fecal transplantation, it is hoped that transplants of vaginal fluids from healthy donors will provide the first restorative, curative treatment for bacterial vaginosis. Published in Frontiers in Cellular and Infection Microbiology, the team's donor screening concept aims to ensure that only beneficial microbes are transferred by VMT - and not potential pathogens.
- Frontiers in Cellular and Infection Microbiology
- National Institutes of Health, Burroughs Wellcome Fund Preterm Birth Initiative